N-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide

C25H34F3N3O2 — CID 66697700

IUPACN-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide
SMILESCCCCn1/c(=N\C(=O)c2cc(C(F)(F)F)ccc2/C=C/C(C)(C)O)cc(C(C)(C)C)n1C
InChIInChI=1S/C25H34F3N3O2/c1-8-9-14-31-21(16-20(30(31)7)23(2,3)4)29-22(32)19-15-18(25(26,27)28)11-10-17(19)12-13-24(5,6)33/h10-13,15-16,33H,8-9,14H2,1-7H3/b13-12+,29-21-
InChIKeyBQLGNDREXHJJNW-AMVUQDNSSA-N
MW465.56 g/mol
LogP5.47
Rot. Bonds6

About N-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide

N-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide (PubChem CID 66697700) has the molecular formula C25H34F3N3O2 and a molecular weight of 465.56 g/mol. Its IUPAC name is N-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide.

Molecular Properties

Compound NameN-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide
PubChem CID66697700
Molecular FormulaC25H34F3N3O2
Molecular Weight465.56 g/mol
Exact Mass465.26
IUPAC NameN-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide
SMILESCCCCn1/c(=N\C(=O)c2cc(C(F)(F)F)ccc2/C=C/C(C)(C)O)cc(C(C)(C)C)n1C
InChIInChI=1S/C25H34F3N3O2/c1-8-9-14-31-21(16-20(30(31)7)23(2,3)4)29-22(32)19-15-18(25(26,27)28)11-10-17(19)12-13-24(5,6)33/h10-13,15-16,33H,8-9,14H2,1-7H3/b13-12+,29-21-
InChIKeyBQLGNDREXHJJNW-AMVUQDNSSA-N
XLogP5.47
TPSA59.52 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms33
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500465.56
LogP ≤ 55.47
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Analyze N-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide?
The IUPAC name of N-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide (CID 66697700) is N-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide.
What is the SMILES notation for N-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide?
The canonical SMILES for N-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide is CCCCn1/c(=N\C(=O)c2cc(C(F)(F)F)ccc2/C=C/C(C)(C)O)cc(C(C)(C)C)n1C.
What is the InChIKey of N-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide?
The InChIKey is BQLGNDREXHJJNW-AMVUQDNSSA-N. The full InChI is InChI=1S/C25H34F3N3O2/c1-8-9-14-31-21(16-20(30(31)7)23(2,3)4)29-22(32)19-15-18(25(26,27)28)11-10-17(19)12-13-24(5,6)33/h10-13,15-16,33H,8-9,14H2,1-7H3/b13-12+,29-21-.
What are the key properties of N-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide?
N-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide has a molecular weight of 465.56 g/mol, XLogP of 5.47, 6 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-(2-butyl-5-tert-butyl-1-methylpyrazol-3-ylidene)-2-[(E)-3-hydroxy-3-methylbut-1-enyl]-5-(trifluoromethyl)benzamide is sourced from PubChem (CID 66697700), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).